Eliminating Duodenoscope-Associated Transmission of Carbapenem-Resistant Enterobacteriaceae (CRE): In Search of an Optimal Strategy

Dig Dis Sci. 2017 Nov;62(11):2961-2963. doi: 10.1007/s10620-017-4761-1.

Authors

Divyanshoo R Kohli¹, Thomas E Grys², Rahul Pannala³

Affiliations

¹ Division of Gastroenterology and Hepatology, Departments of Medicine, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ, 85259, USA.
² Laboratory Medicine, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ, 85259, USA.
³ Division of Gastroenterology and Hepatology, Departments of Medicine, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ, 85259, USA. Pannala.rahul@mayo.edu.

PMID: 28932932
DOI: 10.1007/s10620-017-4761-1

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anti-Bacterial Agents
Carbapenem-Resistant Enterobacteriaceae*
Carbapenems
Cross Infection
Duodenoscopes*
Enterobacteriaceae
Enterobacteriaceae Infections
Humans

Substances

Anti-Bacterial Agents
Carbapenems